Experimental studies with L-asparaginase in mouse leukemias.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000097:blood / Q000627:therapeutic use*; D001216:Asparagine / Q000494:pharmacology; D002330:Carmustine / Q000627:therapeutic use; D002460:Cell Line; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004351:Drug Resistance; D004357:Drug Synergism; D005260:Female; D006207:Half-Life; D006801:Humans; D007942:Leukemia, Experimental / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011033:Podophyllin / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013237:Stereoisomerism; D013866:Thioguanine / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D013997:Time Factors; D014316:Tritium; D014633:Valine / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D009363:Neoplasm Proteins; D011725:Pyridines; D013882:Thiosemicarbazones; D003561:Cytarabine; D014316:Tritium; D003609:Dactinomycin; D001216:Asparagine; D011033:Podophyllin; D001215:Asparaginase; D013866:Thioguanine; D014633:Valine; D002330:Carmustine